AC Immune SA expected to post a loss of 20 rappen a share - Earnings Preview

AC Immune SA

24/07/2023 19:31

* AC Immune SA  ACIU.OQ   ACIU.O  is expected to show a rise
in
quarterly revenue when it reports  results on July 26
(estimated). 
    * The Lausanne Vaud-based  company is expected to report
revenue
of CHF2.5 million, according to the mean estimate from 2
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for AC Immune SA is for
a
loss of 20 rappen per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for AC Immune
SA is
$9​, above​ its last closing price of $3.05. ​​​

This summary was machine generated July 24 at 18:31 GMT.  All
figures in Swiss francs  unless otherwise stated